Research & KnowledgeEvent: September 8, 2026
Epigenome Technologies published an update on Epi-Allele, which elicits compensatory expression of non-targeted alleles and prevents haploinsufficiency in dominant genetic diseases.
Published
Signal category
Research & Knowledge
Quote
“Epigenetics Update - Epi-Allele elicits compensatory expression of the non-targeted allele and prevents haploinsufficiency in dominant genetic diseases”
— Epigenome Technologies team
Company
Epigenome Technologies
Single-cell & Bulk epigenetic services for histones, chromatin remodelers, transcription factors, RNA & DNA methylation
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 8 employees
We specialize in single-cell multi-omics technologies to study the epigenome in normal and disease states. Our proprietary technology, Paired-Tag, can simultaneously profile histone modification state and gene expression from up to a million single cells in parallel.
Founded 2020